A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Brain Tumor · Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · 888-624-1937

Study leads

Jing Wu, M.D.
Principal Investigator
National Cancer Institute (NCI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Brain Metastases, Adult · Brain Tumor - Metastatic · Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Boston, United States

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Brain Tumor · Brain Metastases · Brain Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors

Brain Tumor · Brain Cancer · Motor Cortex; Lesion

Abroad (travel likely)Recruiting

Milwaukee, United States

A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data

Brain (Nervous System) Cancers · Brain Arterial Disease · Neuro-Degenerative Disease

Abroad (travel likely)Recruiting

Changsha, China